SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000200406-24-000071
Filing Date
2024-07-17
Accepted
2024-07-17 08:14:26
Documents
18
Period of Report
2024-07-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20240717.htm   iXBRL 8-K 36389
2 EX-99.1 a2024q2exhibit991.htm EX-99.1 104686
3 EX-99.2 a2024q2exhibit992.htm EX-99.2 1246219
8 image_0a.jpg GRAPHIC 2962
9 image_1a.jpg GRAPHIC 339
  Complete submission text file 0000200406-24-000071.txt   1657933

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20240717.xsd EX-101.SCH 3800
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20240717_def.xml EX-101.DEF 8616
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20240717_lab.xml EX-101.LAB 33327
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20240717_pre.xml EX-101.PRE 20041
20 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20240717_htm.xml XML 7715
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 241120994
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)